NCT06015048 2024-08-05
A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2 Recruiting
Clinical Trials
3 trialsNCT05745740 2023-11-27
A Study of RC48-ADC Combined With Pyrotinib For Treatment of Local Advanced or Metastasis NSCLC With HER2 Mutation
RemeGen Co., Ltd.
Phase 1/2 Unknown
NCT02422199 2018-07-09
A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Breast Cancer Who Have Prior Received Anthracyclin, Taxane or Trastuzumab
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2 Unknown